What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.
about
Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings?Large-Scale Analysis of Drug Side Effects via Complex Regulatory Modules Composed of microRNAs, Transcription Factors and Gene Sets.Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma.Signaling by exosomal microRNAs in cancer.MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.Identification of a blood-borne miRNA signature of synovial sarcoma.RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.Specific miRNA Disease Biomarkers in Blood, Serum and Plasma: Challenges and Prospects.STAT5 induces miR-21 expression in cutaneous T cell lymphoma.Purification and characterization of microRNAs within middle ear fluid exosomes: implication in otitis media pathophysiology.Identification of miR-34a-target interactions by a combined network based and experimental approach.Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteinsThe clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.DNA methylation in urothelial carcinoma.[Research Progress of Exosomes in Lung Cancer Diagnosis and Treatment].Modulation of intracellular calcium signaling by microRNA-34a-5pExpression profiling of peripheral blood miRNA using RNAseq technology in dairy cows with Escherichia coli-induced mastitisMicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
P2860
Q26775704-13B76267-53F5-471B-B110-C79A97C1C9AEQ33921119-9D9A9B0C-FC61-4FA0-A3F5-5F8FC35989B3Q35273600-D7773A6E-2549-40A3-B86D-40BDB0B1754AQ35344075-303D1B96-0F15-460A-BB71-7136C7026C19Q35918962-AE3C54AC-C4EF-460E-9A14-D32540D266ECQ35927721-D528DFCE-897E-4BF9-B9EB-AA7300148FF3Q36278318-F07BA7C5-258B-4C8A-901E-D7601F4B84BAQ36782525-DDA573B5-EA93-4D70-A897-9E560B9C6408Q36994237-656DA44B-982B-402E-B250-A0E17FFB0100Q38815624-48138270-149D-4016-BC9F-1DC5506C9E92Q38886081-96E64F79-CCC8-4CC2-ACAE-40C980547C21Q39665695-1BD49A0F-C987-47E4-A88A-B02DFC323F17Q40346941-E50FD1BF-BEDC-41CC-A783-8FE51CDE24BDQ40769779-8E774448-E0E7-4597-A2C8-93672876C111Q41118667-484FCEE8-7CF0-4546-B534-FFFB6E119F66Q41346414-C4A5C9EB-C361-40DF-B0DC-8DA7CDF5C316Q45937007-0662761D-18CC-4F31-B4D0-468B18DF4365Q53691833-CAB6CB74-B4A7-4EA1-9CEF-226788CE7774Q53760783-D7FB18C2-B46E-45E3-A746-B24A91251D15Q57148008-3BA92C6A-0BE7-4678-B29A-DCE7DACADDFCQ58714778-332CB0C7-71B3-4DCA-8843-8312344B0F2DQ58803658-4033F96C-EDEE-478A-9829-2246A3BEE415
P2860
What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
What makes a blood cell based ...... patients and healthy controls.
@ast
What makes a blood cell based ...... patients and healthy controls.
@en
What makes a blood cell based ...... patients and healthy controls.
@nl
type
label
What makes a blood cell based ...... patients and healthy controls.
@ast
What makes a blood cell based ...... patients and healthy controls.
@en
What makes a blood cell based ...... patients and healthy controls.
@nl
prefLabel
What makes a blood cell based ...... patients and healthy controls.
@ast
What makes a blood cell based ...... patients and healthy controls.
@en
What makes a blood cell based ...... patients and healthy controls.
@nl
P2093
P2860
P356
P1433
P1476
What makes a blood cell based ...... patients and healthy controls.
@en
P2093
Andreas Keller
Christina Backes
Eckart Meese
Hanno Huwer
Indra N Dahmke
Ingo Stehle
Petra Leidinger
Robert Bals
P2860
P304
P356
10.18632/ONCOTARGET.2419
P407
P577
2014-10-01T00:00:00Z